Atara Biotherapeutics (ATRA) Depreciation and Depletion (2013 - 2025)
Atara Biotherapeutics (ATRA) reported Depreciation and Depletion of $100000.0 for Q4 2025, down 80.0% on a YoY basis from $500000.0 in Q4 2024, and down 66.67% quarter-over-quarter from $300000.0 in Q1 2025.
Atara Biotherapeutics (ATRA) Depreciation and Depletion (2013 - 2025) Analysis & Trends
Atara Biotherapeutics has reported Depreciation and Depletion for 9 years, with the latest figure at $100000.0 in Q4 2025.
- For the quarter ending Q4 2025, Depreciation and Depletion fell 80.0% year-over-year to $100000.0; the trailing twelve-month figure through Dec 2025 stood at $400000.0 (down 85.19% YoY), and the FY2025 full-year result was $400000.0, down 85.19% from the prior year.
- Depreciation and Depletion for Q4 2025 stood at $100000.0, down from $300000.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $1.5 million in Q1 2022, with the low at $100000.0 in Q4 2025.
- Historically, Depreciation and Depletion has averaged $828571.4 across 4 years, with a median of $900000.0 in 2022.
- Annual changes were most pronounced in 2023 — Depreciation and Depletion changed 0.0% — and 2025, when it slumped 80.0%.
- Atara Biotherapeutics' Depreciation and Depletion stood at $900000.0 in 2022, then changed by 0.0% to $900000.0 in 2023, then sank by 44.44% to $500000.0 in 2024, then tumbled by 80.0% to $100000.0 in 2025.
- The last three Depreciation and Depletion figures came in at $100000.0 (Q4 2025), $300000.0 (Q1 2025), and $500000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Atara Biotherapeutics | 134.61 Mn | 126.21 Mn | 392,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 100,000.00 |
| Dec 31, 2025 | 100,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | 500,000.00 |
| Dec 31, 2024 | 500,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Sep 30, 2024 | 600,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Mar 31, 2024 | 900,000.00 |
| Mar 31, 2024 | 900,000.00 |
| Dec 31, 2023 | 900,000.00 |
| Dec 31, 2023 | 900,000.00 |
| Sep 30, 2023 | 900,000.00 |
| Sep 30, 2023 | 900,000.00 |
| Jun 30, 2023 | 900,000.00 |
| Jun 30, 2023 | 900,000.00 |
| Mar 31, 2023 | 900,000.00 |
| Mar 31, 2023 | 900,000.00 |